Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells

<div>Cytotoxicity of ZER-NLC, ZER, NLC, DMSO, and DOXO treatments on canine mammary gland tumor (CMT) adenocarcinoma cells at (a) 24, (b) 48, and (c) 72 h. For each concentration, means with different roman numerals were significantly different (<i>p</i>&lt;0.05) from each other. DMSO: dimethyl sulfoxide; DOXO: doxorubicin; NLC: nanostructured lipid carrier; ZER: zerumbone; ZER-NLC: zerumbone-loaded nanostructured lipid carrier.</div>

BioMed Research International

fig7

Figure 7

Figure 7: Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells 